<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:x="urn:schemas-microsoft-com:office:excel"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Excel.Sheet>
<meta name=Generator content="Microsoft Excel 15">
<link id=Main-File rel=Main-File href="../17470824_2.xlsx.html">
<link rel=File-List href=filelist.xml>
<link rel=Stylesheet href=stylesheet.css>
<style>
<!--table
	{mso-displayed-decimal-separator:"\.";
	mso-displayed-thousand-separator:"\,";}
@page
	{margin:.75in .7in .75in .7in;
	mso-header-margin:.3in;
	mso-footer-margin:.3in;}
-->
</style>
<![if !supportTabStrip]><script language="JavaScript">
<!--
function fnUpdateTabs()
 {
  if (parent.window.g_iIEVer>=4) {
   if (parent.document.readyState=="complete"
    && parent.frames['frTabs'].document.readyState=="complete")
   parent.fnSetActiveSheet(0);
  else
   window.setTimeout("fnUpdateTabs();",150);
 }
}

if (window.name!="frSheet")
 window.location.replace("../17470824_2.xlsx.html");
else
 fnUpdateTabs();
//-->
</script>
<![endif]>
</head>

<body link="#0563C1" vlink="#954F72">

<table border=0 cellpadding=0 cellspacing=0 width=320 style='border-collapse:
 collapse;table-layout:fixed;width:240pt'>
 <col width=64 span=5 style='width:48pt'>
 <tr height=20 style='height:15.0pt'>
  <td height=20 colspan=5 width=320 style='height:15.0pt;mso-ignore:colspan;
  width:240pt'>Figure 3. Summary of subgroup efficacy results.</td>
 </tr>
 <tr height=40 style='height:30.0pt;mso-xlrowspan:2'>
  <td height=40 colspan=5 style='height:30.0pt;mso-ignore:colspan'></td>
 </tr>
 <tr height=262 style='mso-height-source:userset;height:196.9pt'>
  <td height=262 class=xl66 style='height:196.9pt'>Variable</td>
  <td class=xl67 width=64 style='width:48pt'>Placebo Croup, <font class="font7">n/n
  (%)</font></td>
  <td class=xl67 width=64 style='width:48pt'>Adalimumab Croup, <font
  class="font7">n/n (%)</font></td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=20 style='height:15.0pt'>
  <td colspan=3 height=20 class=xl65 style='height:15.0pt'>Primary analysis</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=20 style='height:15.0pt'>
  <td height=20 class=xl65 style='height:15.0pt'>Remission in <span
  style='display:none'>overall population</span></td>
  <td class=xl68>12/66(7)</td>
  <td class=xl65>34/159 (21)</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=20 style='height:15.0pt'>
  <td colspan=3 height=20 class=xl65 style='height:15.0pt'>Prespecified
  subgroup analyses</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=20 style='height:15.0pt'>
  <td height=20 class=xl65 style='height:15.0pt'>Remission</td>
  <td class=xl69></td>
  <td class=xl70></td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=20 style='height:15.0pt'>
  <td height=20 class=xl71 style='height:15.0pt'>Patients with <span
  style='display:none'>previous loss of response to infliximab</span></td>
  <td class=xl68>7/87(8)</td>
  <td class=xl72>15/77(20)</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=20 style='height:15.0pt'>
  <td height=20 class=xl71 style='height:15.0pt'>Patients with <span
  style='display:none'>previous intolerance of infliximab</span></td>
  <td class=xl68>5/95(5)</td>
  <td class=xl72>21/95(22)</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=20 style='height:15.0pt'>
  <td height=20 class=xl71 style='height:15.0pt'>Patients with <span
  style='display:none'>baseline CRP concentration &lt;10 mg/L</span></td>
  <td class=xl68>7/98(7)</td>
  <td class=xl72>15/82 (18)</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=20 style='height:15.0pt'>
  <td height=20 class=xl73 style='height:15.0pt'>Patients with <span
  style='display:none'>baseline CRP concentration £10 mg/L</span></td>
  <td class=xl74>5/68(7)</td>
  <td class=xl75>19/77(25)</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=20 style='height:15.0pt'>
  <td colspan=3 height=20 class=xl65 style='height:15.0pt'>Additional subgroup
  analyses</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=20 style='height:15.0pt'>
  <td height=20 class=xl65 style='height:15.0pt'>Remission</td>
  <td class=xl69></td>
  <td class=xl70></td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=20 style='height:15.0pt'>
  <td height=20 class=xl71 style='height:15.0pt'>Patients not r<span
  style='display:none'>eceiving immunosuppressive agents at baseline</span></td>
  <td class=xl68>6/81 (7)</td>
  <td class=xl72>18/86(21)</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=20 style='height:15.0pt'>
  <td height=20 class=xl71 style='height:15.0pt'>Patients recei<span
  style='display:none'>ving immunosuppressive agents at baseline</span></td>
  <td class=xl68>6/85(7)</td>
  <td class=xl72>16/73(22)</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=20 style='height:15.0pt'>
  <td height=20 class=xl73 style='height:15.0pt'>Patients not r<span
  style='display:none'>eceiving corticosteroids at baseline</span></td>
  <td class=xl74>9/93 (10)</td>
  <td class=xl76>16/104(15)</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=86 style='mso-height-source:userset;height:64.5pt'>
  <td height=86 class=xl71 style='height:64.5pt'>Patients recei<span
  style='display:none'>ving corticosteroids at baseline</span></td>
  <td class=xl68>3/73 (4)</td>
  <td class=xl72>18/55(33)</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=121 style='mso-height-source:userset;height:90.75pt'>
  <td height=121 class=xl77 width=64 style='height:90.75pt;width:48pt'>Patients
  with previous loss of response to and intolerance of infliximab*</td>
  <td class=xl78>0/21 (0)</td>
  <td class=xl78>3/19(16)</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=121 style='mso-height-source:userset;height:90.75pt'>
  <td height=121 class=xl77 width=64 style='height:90.75pt;width:48pt'>Patients
  who received negative results on test for antibodies to infliximabt</td>
  <td class=xl68>7/91 (8)</td>
  <td class=xl72>19/88(22)</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=132 style='mso-height-source:userset;height:99.0pt'>
  <td height=132 class=xl77 width=64 style='height:99.0pt;width:48pt'>Patients
  who received indeterminate results on test for antibodies to infliximabt</td>
  <td class=xl68>2/8(25)</td>
  <td class=xl68>2/12 (17)</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=123 style='mso-height-source:userset;height:92.25pt'>
  <td height=123 class=xl79 width=64 style='height:92.25pt;width:48pt'>Patients
  who received positive results on test for antibodies to infliximabt</td>
  <td class=xl68>2/60(3)</td>
  <td class=xl72>11/50(22)</td>
  <td colspan=2 style='mso-ignore:colspan'></td>
 </tr>
 <tr height=80 style='height:60.0pt;mso-xlrowspan:4'>
  <td height=80 colspan=5 style='height:60.0pt;mso-ignore:colspan'></td>
 </tr>
 <tr height=98 style='mso-height-source:userset;height:73.5pt'>
  <td height=98 colspan=5 style='height:73.5pt;mso-ignore:colspan'></td>
 </tr>
 <![if supportMisalignedColumns]>
 <tr height=0 style='display:none'>
  <td width=64 style='width:48pt'></td>
  <td width=64 style='width:48pt'></td>
  <td width=64 style='width:48pt'></td>
  <td width=64 style='width:48pt'></td>
  <td width=64 style='width:48pt'></td>
 </tr>
 <![endif]>
</table>

</body>

</html>
